Tissue Repair
Type Mechanism / biological process
Key peptides BPC-157, GHK-Cu
Overview
Tissue repair is the convergence point for peptides that rebuild structural tissue — tendon, bone, muscle, vasculature, and GI mucosa. The two primary mechanisms are angiogenesis (building new blood vessels to supply repair) and ECM remodeling (direct collagen/elastin synthesis and scar clearance).
Angiogenesis — Building the Blood Supply
Primary driver: VEGFR2 → Akt → eNOS cascade
| Peptide | Mechanism | Notes |
|---|---|---|
| BPC-157 | VEGFR2 upregulation + internalization; decreases eNOS/Caveolin-1 binding ~50% | Bidirectional NO modulation; rescues completely excised femoral arteries |
| GHK-Cu | Angiogenesis via SIRT1/STAT3 pathway | Also MMP/TIMP balanced remodeling of the vessels themselves |
Without angiogenesis: new tissue is avascular → necrotic → fibrotic scar.
Key principle: BPC-157 constructs the vascular supply; GHK-Cu builds the architecture around it. TB-500 provides the systemic cell-mobilization logistics — delivering the repair workforce to BPC-157’s prepped site from across the body.
Wolverine Stack: BPC-157 + TB-500 — the canonical catastrophic injury repair protocol. BPC builds local structure; TB-500 recruits fibroblasts, endothelial cells, and immune cells systemically.
ECM Remodeling — Building the Structure
Primary driver: Collagen synthesis + MMP/TIMP balance
| Component | Role |
|---|---|
| COL1A1, COL3A1 | Fibrillar collagen (tendon, bone, skin) |
| Elastin, Fibronectin, Laminin | Elasticity, cellular adhesion, ECM integrity |
| Decorin | Organizes collagen fibrillogenesis → basket-weave pattern, not scar bundles |
| MMP-1, MMP-2 | Dissolves disorganized (scar) collagen |
| TIMP-1, TIMP-2 | Prevents over-digestion of healthy tissue |
GHK-Cu uniquely upregulates ALL of these simultaneously, maintaining MMP/TIMP balance.
GHR Upregulation — The Force Multiplier
BPC-157 upregulates GHR up to 7× — sensitizing tissue to endogenous GH. This makes it a force multiplier for any GH secretagogue (CJC-1295/Ipamorelin).
FAK-Paxillin — Cell Migration
FAK-paxillin is the mechanosensory pathway that translates extracellular cues into cell migration:
- BPC-157 activates it → enhanced fibroblast migration → faster wound gap closure
- GHK-Cu suppresses it → anti-metastatic cancer protection
This is why GHK-Cu makes BPC-157 safer: it acts as a biological governor on the same pathway.
The “Wolverine Stack”
BPC-157 + TB-500
- BPC-157: rapid angiogenesis + tissue bridging near injury site
- TB-500: systemic actin remodeling + fibroblast motility + scar clearance
- BPC builds → TB-500 recruits repair cells from across the body
Anti-Inflammatory Overlay
BPC-157, GHK-Cu, and TB-500 all suppress NF-κB — but via different mechanisms:
| Peptide | NF-κB Mechanism |
|---|---|
| BPC-157 | Blocks TNF-α → IKK → IκB degradation upstream |
| GHK-Cu | Removes oxidative trigger (ROS/LDL oxidation) upstream |
| TB-500 | Physically binds PINCH-1/ILK — downstream execution block |
This makes them complementary, not redundant — three different checkpoints in the same inflammatory cascade.
Links
- BPC-157 (primary angiogenesis driver)
- GHK-Cu (ECM architect + safety counterbalance)
- TB-500 (systemic repair cell mobilization)
- Peptides MOC
- Genomic Remodeling (GHK-Cu’s broader mechanism)
Source: Gemini Deep Research corpus · PeptideDosages.com 2026-03-20